Americann (ACAN) Stock Price

Americann Price

OTC·CLOSED
0.00
​
Market closed

Revenue has compounded at 45.5% per year over the past 10 years to 1.28 M USD. Americann's net margin stands at -98.4%, up from -140.8% several years earlier.

Americann stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Americann business model & stock analysis

Americann Inc is a US-based company that specializes in the legalization and cultivation of cannabis-based products. It was founded in 2010 by Tim Keogh, an experienced entrepreneur and investor. Americann's business model focuses on creating value through investments in various sectors of the cannabis industry. This includes companies involved in cultivation and production, technology and innovation, as well as sales and distribution. The company aims to achieve diversification in its investments to create long-term value for its investors. Americann does not offer its own products or services, but instead invests in companies within the cannabis industry.

Frequently asked questions about Americann

Americann Inc is a leading company in the cannabis industry. Their business model focuses on cultivating and processing medical and adult-use cannabis. With state-of-the-art facilities, Americann Inc produces high-quality cannabis products that meet the needs of both medical patients and recreational consumers. By leveraging advanced technology and innovative practices, the company ensures consistent quality and potency across their product range. Americann Inc also seeks to build partnerships and develop strategic relationships to expand their market presence and enhance distribution. Through their commitment to excellence and dedication to serving the growing demand for cannabis, Americann Inc is poised for continued success in the industry.

Americann Inc is primarily active in the cannabis industry.

The main competitors of Americann Inc in the market include companies like MedMen Enterprises Inc, Curaleaf Holdings Inc, Canopy Growth Corporation, Tilray Inc, and Aurora Cannabis Inc.

Americann Inc is a renowned American company specializing in the cannabis industry. Established in 2010, Americann Inc has consistently been at the forefront of marijuana cultivation and development. The company focuses on the innovative cultivation and processing of medical cannabis, utilizing advanced technologies and sustainable practices. Americann Inc aims to provide reliable, high-quality cannabis products to support wellness and improve the lives of patients. With a distinguished history in cannabis cultivation, Americann Inc has transformed into a leading player in the industry, constantly adapting and growing to meet the evolving demands of the market.

Americann Inc, a leading company in the stock market, has achieved several significant milestones in its journey. The company has successfully expanded its operations and gained recognition as a trusted player in the industry. Americann Inc has achieved impressive financial growth, increasing its market share and delivering strong returns to its investors. The company has strategically entered into profitable partnerships and collaborations, further enhancing its reach and market reputation. With its innovative approach and commitment to excellence, Americann Inc has positioned itself as a frontrunner in the stock market, solidifying its position as a lucrative investment option for individuals seeking long-term growth and profitability.

Americann Inc is primarily present in the United States. As a leading cannabis company, Americann operates in multiple states across the country, including Massachusetts, Colorado, and Illinois. With a strong focus on cultivating, processing, and distributing top-quality medical and adult-use cannabis products, Americann serves customers and patients in these regions. Additionally, the company is continuously expanding its reach and market presence to capitalize on the growing cannabis industry in the United States.

Americann Inc is a renowned company that upholds the values of integrity, innovation, and sustainability in its operations. With a strong corporate philosophy, Americann Inc aims to provide exceptional services and products in the stock market. The company is committed to transparency, ensuring reliable and trustworthy information for investors. Americann Inc strives to foster growth and profitability while prioritizing ethical practices and responsible decision-making. By emphasizing these values, Americann Inc sets itself apart in the industry and reinforces its dedication to delivering value to its shareholders and stakeholders.

Converted at the current exchange rate, the Americann share trades at 0.00 EUR (0.00 USD).

Americann Inc is a leading operator of legal marijuana facilities in the USA. The company offers a wide range of products and services for the cultivation, production, and sale of medical and recreational marijuana for customers in the USA. The company's business model includes various divisions such as cultivation facilities, cannabis processing facilities, and stores for the legal sale of marijuana. Americann operates multiple large-scale cultivation facilities in various states, equipped with modern technologies for high-quality and efficient marijuana production. The company also partners with small cultivation operations to avoid production shortages. Americann's processing facilities contribute to the production of tailored cannabis products for different markets, including various strains, tinctures, oils, capsules, and vape products. The company operates both physical retail stores and an online shop to meet the needs of a wide range of customers, with well-trained staff providing personalized recommendations. Americann has also introduced a luxury brand called "Omni," focusing on the high-end market for cannabis products. The company emphasizes research and development to continuously improve product quality and meet customer needs. In conclusion, Americann is a leading operator of legal marijuana facilities in the USA, offering a diverse range of products and services for cultivation, production, and sale of medical and recreational marijuana. The company's vertically integrated production chain caters to the needs of customers in various markets. Through research and development, Americann constantly strives to improve product quality and better meet the needs of its customers.

The revenue cannot currently be calculated for Americann.

The profit cannot currently be calculated for Americann.

The P/E ratio cannot be calculated for Americann at the moment.

The P/S cannot be calculated for Americann currently.

The Eulerpool Quality Score for Americann is 2/10.

The ISIN of Americann is US0305881072. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Americann is A2JB1Y. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Americann is ACAN. The ticker symbol is used to trade Americann shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
425,000.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website americann.co
Currency
USD
Initial public offering
Sep 10, 2013
ISIN
US0305881072
Cusip
030588107
Sedol
BLSP9Q2
Market capitalization
2,439.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-13.15 %
Last updated Oct 19, 2026, 4:03 PM

Americann Ticker

OTC · ACANOTC · ACAN

Americann FIGI

ACAN:US · BBG005806K26ACAN:PQ · BBG005806KJ8ACAN:UV · BBG005806KL5

All fundamentals and in-depth analysis of Americann

Our stock analysis for Americann stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Americann. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.